Risk of Myocardial Infarction or Vascular Death After First Ischemic Stroke
Open Access
- 1 June 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 38 (6) , 1752-1758
- https://doi.org/10.1161/strokeaha.106.480988
Abstract
Background and Purpose— In national guidelines, absolute long-term risk of myocardial infarction (MI) or coronary death determines target low-density lipoprotein levels, but stroke patients are not explicitly addressed. We determined the absolute 5-year risk of cardiovascular outcomes and their predictors after first ischemic stroke in a multiethnic cohort. Methods— A population-based cohort of first ischemic stroke patients ≥40 years old was prospectively followed annually for recurrent stroke, MI and cause-specific mortality. Kaplan-Meier 5-year risks for MI or vascular death (primary outcome), and other cardiovascular events, were calculated. Univariate and multivariate Cox proportional hazards models were used to calculate hazard ratios and 95% CI for predictors of cardiovascular outcomes. Results— Mean age (n=655) was 69.7±12.7 years; 55.4% of participants were women, and 51.3% Hispanic. The 5-year risk of MI or vascular death was 17.4% (95% CI, 14.2% to 20.6%). Independent historical predictors of MI or vascular death were age >70 years (hazard ratio 1.62, 1.07 to 2.44), history of coronary artery disease (hazard ratio 1.76, 1.13 to 2.74), and atrial fibrillation (hazard ratio 1.76, 1.05 to 2.94). In the lowest risk group, those ≤70 years old without coronary artery disease, 5-year risk of MI or vascular death was 9.7%. Conclusions— The absolute risk of MI or vascular death after ischemic stroke, even in those without high-risk features, approximates levels used by national organizations to designate groups of patients at high risk of vascular events. The comparability of levels of absolute risk among stroke and cardiac patients may have treatment implications.Keywords
This publication has 24 references indexed in Scilit:
- Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic AttackStroke, 2006
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- European guidelines on cardiovascular disease prevention in clinical practiceAtherosclerosis, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- The Protective Effect of Moderate Alcohol Consumption on Ischemic StrokeJAMA, 1999
- Cardiac evaluation of stroke patientsNeurology, 1998
- Stroke Incidence among White, Black, and Hispanic Residents of an Urban Community: The Northern Manhattan Stroke StudyAmerican Journal of Epidemiology, 1998
- Design of the trial of Org 10172 in acute stroke treatment (TOAST)Controlled Clinical Trials, 1997
- Testing the validity of the lacunar hypothesisNeurology, 1997
- Serum Carotenoids and Coronary Heart DiseaseJAMA, 1994